Utama › Penyakit Paru Interstisial › Virginia
Kajian klinikal Penyakit Paru Interstisial di Virginia
8 kajian untuk Penyakit Paru Interstisial sedang mencari peserta di lokasi di Virginia.
Bandar di Virginia
Teks kajian rasmi (Bahasa Inggeris)
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
- Virginia Commonwealth University, Richmond
Mengambil pesertaFasa 3
Umur 40 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07201922Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA008, Richmond
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07179380Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- Virginia Commonwealth University, Richmond
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT06911632DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Inova Medical Group, Falls Church
- Sentara Norfolk General Hospital, Norfolk
- Pulmonary Associates of Richmond, Inc., Richmond
- dan 1 lagi
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT06388421PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
- University of Virginia, Charlottesville
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 80 · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT06855329Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Inova, Falls Church
Mengambil pesertaKajian pemerhatian
Umur 21 ke atas · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT01915511Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- University of Virginia Health System, Charlottesville
- Christopher King, MD, Falls Church
- Pulmonary Associates of Richmond, Inc., Richmond
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Jul 2026 · NCT05943535Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
- aTyr Investigative Site, Richmond
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Mei 2025 · NCT05892614Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.